1. Home
  2. VHC vs NSRX Comparison

VHC vs NSRX Comparison

Compare VHC & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirnetX Holding Corp

VHC

VirnetX Holding Corp

N/A

Current Price

$18.01

Market Cap

79.2M

Sector

Miscellaneous

ML Signal

N/A

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$7.35

Market Cap

63.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VHC
NSRX
Founded
2005
2019
Country
United States
Israel
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
63.4M
IPO Year
1999
2025

Fundamental Metrics

Financial Performance
Metric
VHC
NSRX
Price
$18.01
$7.35
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$20.50
AVG Volume (30 Days)
27.2K
5.6K
Earning Date
11-14-2025
02-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$106,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2020.00
N/A
52 Week Low
$5.01
$5.90
52 Week High
$29.00
$9.99

Technical Indicators

Market Signals
Indicator
VHC
NSRX
Relative Strength Index (RSI) 44.57 N/A
Support Level $16.32 N/A
Resistance Level $19.16 N/A
Average True Range (ATR) 1.78 0.00
MACD -0.10 0.00
Stochastic Oscillator 32.61 0.00

Price Performance

Historical Comparison
VHC
NSRX

About VHC VirnetX Holding Corp

VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: